In 2026, artificial intelligence is no longer a futuristic concept in healthcare, it’s actively working alongside dentists across the country. The American Dental Association has been at the forefront ...

By allowing lawsuits to proceed, a federal judge may be opening the door to broader liability for AI tool vendors, and ...

The accessibility tree decides whether an AI agent can read and act on your page. The 2026 data says the web is getting ...

Tidepool, the nonprofit leader advancing innovation in diabetes technology, today unveiled new clinical insights and research initiatives in conjunction with the American Diabetes Association’s (ADA) ...

Cardano active addresses have spiked for the second time this month as ADA trades near 2020 lows. A Cardano-based wallet protocol was exploited for nearly 129 million ADA, worth roughly $20 million.

Ranked by market capitalization at the time of writing (June 26, 2026, mid-correction prices), the ten largest ...

Boehringer Ingelheim revealed more data behind previously reported top-line results for its dual-acting obesity drug survodutide, including strong activity against visceral and liver fat. The efficacy ...

Cardano whales kept buying ADA in late June even as transactions, smart contract use, and fees fell to a 45-day low.

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

New ADA 2026 data show diabetic ketoacidosis hospitalizations rising 24%, driven by poor ketone monitoring and symptom recognition gaps across all ages. A key driver of that burden is recognition—or ...

AstraZeneca is preparing to move its oral GLP-1 agonist elecoglipron into a phase 3 programme in obesity and type 2 diabetes, after reporting encouraging mid-stage results. The results of the phase 2b ...